INGEVITY CORPORATION (NGVT): what the price assumes
In the published model solve dated 2026-Q2, anchored at $77.32, INGEVITY CORPORATION (NGVT) is priced for -4.2% growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-06-27.
Generated: 2026-08-10 · Exported: 2026-08-12 · Source: https://boothcheck.com/report/NGVT
Headline
| Field | Value |
|---|---|
| Ticker | NGVT |
| Company | INGEVITY CORPORATION |
| Current price | $77.32/sh |
| Composition | Performance Materials segment 52% / Performance Chemicals segment 34% / Advanced Polymer Technologies segment 14% |
What The Price Assumes (Inversion)
The assumption today's price embeds, recovered by inverting the valuation.
| Field | Value |
|---|---|
| Inversion basis | whole-company |
| Implied growth | -4.2% |
| Multiple paid | 9x operating income |
Solve inputs: computed at a 10% cost of capital with 4% terminal growth over a 5-year stage; each 1pp of cost of capital moves the implied operating-profit growth ~4.4pp.
How unusual the bet is: within-range
| Reference | Value |
|---|---|
| vs own history | -0.86σ |
| cohort percentile (of 77 peers) | 5 |
| implied end-window share | 0% |
Valuation X-Ray
Asset, earnings-power and peer-multiple models all land far below the price; ONLY the growth-DCF reaches it. The bet is durable compounding the static frames structurally cannot price (a moat/durability premium).
How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.
| Family | Median price/FV | Models | Reads |
|---|---|---|---|
| Asset | 3.62x | 4 | expensive |
| Earnings | 1.79x | 4 | expensive |
| Relative | — | 0 | — |
| Growth | 0.88x | 3 | justifies |
Families that justify the price: Growth Families that call it expensive: Asset, Earnings
The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 8.9%); the inversion above states its own rate.
Per-Model Detail (n=11)
| Model | Family | FV | Price/FV | Applicable | Methodology |
|---|---|---|---|---|---|
| DCF Perpetual Growth | Growth | $104.57 | 0.74x | yes | FCF base $0.2B, growth 9% (input: historical growth), terminal g 4.0%, WACC 8.9%, 6yr projection |
| DCF Exit Multiple | Growth | $88.34 | 0.88x | yes | Exit EV/EBITDA: 118.7x / 120.7x / 122.7x (bear / base = today's held flat / bull), 6yr |
| Relative Valuation | Relative | — | — | no | P/E 24.57x (blended: static sector reference 14x + trailing (TTM) 49x), scenarios: 20.5x / 24.6x / 28.6x (bear / base = reference held flat / bull), EV/EBITDA 17.6x |
| Simple DDM | Growth | — | — | no | — |
| Two-Stage DDM | Growth | — | — | no | — |
| Simple Excess Return | Asset | $16.98 | 4.55x | yes | BV/sh $1.36, ROE (TTM) 115.1%, ke 9.3% |
| Two-Stage Excess Return | Asset | $150.60 | 0.51x | yes | 5yr excess ROE then converge to ke=9.3% |
| Discounted Future Market Cap | Growth | $63.93 | 1.21x | yes | Rev $1.1B, growth 9% (input: historical growth; tapered), Terminal P/S: 2.0x / 2.4x / 2.8x (bear / base = today's held flat / bull, cap 8x) |
| Growth-Adjusted P/E | Relative | — | — | no | — |
| Margin Trajectory | Growth | — | — | no | — |
| Earnings Power Value | Earnings | $108.91 | 0.71x | yes | Normalized EBIT (5y avg op income, one-time charges added back) $0.45B × (1−21%) / WACC 8.9% → EPV (no growth) |
| Residual Income | Asset | $28.83 | 2.68x | yes | BV $1.36 + 5yr PV of (ROE (TTM) 115.1% − Kₑ 9.3%) × BV; BV grows 8.8%/yr |
| Graham Number | Asset | $6.81 | 11.35x | yes | √(22.5 × EPS $1.51 × BVPS $1.36) — Graham's conservative floor |
| EV/EBITDA Relative | Relative | — | — | no | EBITDA $0.02B × sector EV/EBITDA 8.0x |
| FCF Yield | Earnings | $46.31 | 1.67x | yes | FCF $154.9M / Kₑ 9.3% — zero-growth perpetuity |
| SBC-Adj FCF Yield | Earnings | $40.39 | 1.91x | yes | SBC-adj FCF $0.14B (FCF $0.15B − SBC $0.02B) capitalized at Kₑ |
| Ben Graham Formula | Earnings | $1.27 | 60.88x | yes | EPS $1.51 × (8.5 + 2×-5.0%) × (4.4 / 5.3%) (excluded from median) |
| ROIC-Justified P/B | Asset | — | — | no | — |
| P/Sales Sector | Relative | — | — | no | Revenue $1.09B × sector P/S 1.5x |
| PEG Fair Value | Relative | — | — | no | — |
| Earnings Yield | Earnings | $16.32 | 4.74x | yes | EPS $1.51 / required return 9.3% (Rf 4.3% + ERP 5.0%) |
| Funds From Operations Multiple | Relative | — | — | no | — |
| Clinical Phase NPV | Growth | — | — | no | — |
| Merton | Asset | — | — | no | — |
| V5 Mechanical | — | — | — | no | — |
Economic-Unit Decomposition (Sum Of The Parts)
One or more material disclosed units has unresolved economics. Unknown/general is not evidence of homogeneity: segment SOTP is primary but incomplete, consolidated cash flow may remain only a secondary cross-check when every unit shares an enterprise basis, and one sector multiple or target margin is withheld.
| Unit | Role | Valuation basis | Revenue | Reported profit | Value evidence | Status |
|---|---|---|---|---|---|---|
| Performance Materials | operating | enterprise | $606.9m | — | $5.2b indicative EV subtotal | indicative enterprise value |
| Performance Chemicals | operating | enterprise | $400.5m | — | withheld | unresolved no unit value |
| Advanced Polymer Technologies | operating | enterprise | $160.2m | — | $514.0m indicative EV subtotal | indicative enterprise value |
No total common-equity value is stated. One or more material units lack a supported unit value. The displayed values are an indicative subtotal; consolidated debt and cash cannot be applied to a fraction of the company.
Solvency
| Field | Value |
|---|---|
| Net debt | $1.1b |
| Net debt / NOPAT (after-tax) | 3.36x |
| Net debt / operating income (pre-tax) | 2.63x |
| Interest coverage | 5.3x |
| Share count CAGR (buyback) | -2.3% |
| Burning cash | no |
Bullet Takeaways
- Ingevity's most distinctive asset is its Performance Materials segment, the activated carbon that captures gasoline vapor in vehicle fuel systems, a high-margin niche where the company is a leader and which carries the consolidated 33.9% operating margin.
- The largest specific risk is structural and long-dated: automakers are adopting sealed fuel tanks and shifting toward electric vehicles, both of which reduce the need for the carbon that drives Ingevity's best segment.
- Watch the portfolio cleanup, including the divested Road Markings line and the North Charleston crude tall oil refinery, against reaffirmed 2026 guidance of $1.05 to $1.15 billion in net sales and $370 to $395 million in adjusted earnings before interest, tax, depreciation and amortization.
Bull Case
Look first at how far the price sits below where the methods land, because that gap is the bull case. The earnings-power lens and the cash-flow methods both reach today's price or sit above it, which means the market is paying roughly what the demonstrated profit and a modest growth path justify, not a premium on top of them. Reading the price backward makes the point sharper: at today's level the market is pricing operating profit to shrink about 3% a year for five years. The bull case does not need growth to win. It needs Ingevity to simply not decline as much as the price assumes.
The reason that is plausible is the quality of the core franchise. Ingevity operates in three segments, and its Performance Materials business makes the activated carbon that captures gasoline vapor in vehicle fuel systems. The filing describes the mechanism plainly: captured vapors "are largely purged from the activated carbon and re-directed to the engine where they are used as supplemental power for the vehicle." That is a specified, regulation-driven product with high barriers, and it is what holds the consolidated operating margin near 34%. Profitability stayed resilient through a noisy quarter, with adjusted earnings margin around 35.5%, which is the signal that the core economics are intact even while the company reshapes the rest.
Management is using the cash and the portfolio actively, which is the second pillar. Ingevity has been shrinking its share count, down about 2% a year, and it completed a series of divestitures, selling the Ozark Materials road-markings line, the North Charleston crude tall oil refinery, and most of its industrial specialties product line. These were the lower-margin, more cyclical pieces, and shedding them concentrates the company on its better businesses. Pricing actions in Performance Materials and pavement technologies, helped by foreign exchange, lifted first-quarter revenue 4.1% to $258 million, ahead of expectations. A buyer at today's price is paying for a high-margin specialty franchise priced as if it slowly fades, with management actively pruning the weak parts and buying back stock.
Bear Case
The competitive threat to Ingevity's best business is not a rival chemical maker, it is the car itself changing. Performance Materials earns its margin from activated carbon that captures gasoline vapor, and that demand exists only because internal-combustion vehicles release those vapors. The company's own filing names the substitution directly: "multiple OEMs are using sealed tanks in certain subsets of their vehicles to comply with the strict emission regulations" such as the U.S. Tier 3 and LEV III standards. Sealed tanks need less carbon, and electric vehicles need none. The single most profitable segment is tied to a powertrain the industry is slowly engineering away from, and that erosion is structural, not cyclical.
Performance Chemicals, the other major segment, shows a different kind of fragility: thin and volatile margins. In the first quarter the segment's adjusted earnings margin fell to around 1%, which management attributed to lower plant utilization in road markings and higher supply-chain and overhead costs. The business also rests on commodity inputs whose prices the company does not control. The filing lists key raw materials including "maleic anhydride, ethoxylates, amines, and acrylic emulsions" for Performance Chemicals, and notes that the prices of its tall-oil feedstocks track "actual and expected harvest rates, petroleum oil prices, and the biofuel market." When feedstock costs rise and utilization falls at the same time, a low-margin chemicals business swings quickly from profit to loss.
The valuation read is more nuanced than a simple cheap-or-rich verdict. The earnings-power and cash-flow methods support the price, but the peer-multiple comparison reads it as roughly 48% above where its specialty-chemicals peers trade. The price is paying about nine times operating income, which embeds a gentle decline rather than growth, so the bear is not arguing the stock is wildly overvalued. The bear is arguing the gentle-decline assumption could prove optimistic if Performance Materials erodes faster than expected and Performance Chemicals stays at razor-thin margins. Net debt sits near $987 million, about 2.5 times operating income, a manageable load for a profitable specialty maker but one that leaves less room if the better segment fades while the weaker one struggles to recover utilization.
Valuation
The price is making a quiet bet, and naming it changes how the stock reads. At today's level the market is paying about nine times operating income, which works out to pricing operating profit to decline roughly 3% a year for five years. This is not a growth stock priced for acceleration; it is a profitable specialty business priced as if it slowly shrinks. The framework reads that embedded assumption as within range of what is plausible, because the recent pace is consistent with what the company has delivered. The whole question is whether the decline the price assumes is too pessimistic, about right, or not pessimistic enough.
The methods split in a way that frames it as a value name rather than a growth bet. The earnings-power lens sits essentially at the price, and the cash-flow methods sit just above it, both saying the demonstrated profit and a modest path justify today's level. The peer-multiple comparison is the dissenter, placing the price around 48% above where the chosen specialty-chemicals peers trade. That spread is the tension: the absolute-value methods say the earnings support the price, while the relative lens says it looks dear next to its cohort. For a business undergoing a portfolio overhaul, the absolute methods deserve the heavier weight, because the peer set mixes companies with different segment economics and the comparison is sensitive to which peers are chosen.
Solvency is comfortable enough to keep the focus on the operating question. Net debt of about $987 million is roughly 2.5 times operating income, and trailing operating profit near $399 million on a 34% margin gives the company room to service it and keep buying back stock. Interest expense is not separately broken out in the latest filings, so a precise coverage figure is not available, but the leverage ratio and the margin profile point to a balance sheet that is not the binding constraint. The decisive variable is the durability of Performance Materials.
Catalysts
The portfolio reshaping is the catalyst that defines the next year. Ingevity completed the sale of its Ozark Materials road-markings product line, divested its North Charleston crude tall oil refinery, and sold the majority of its industrial specialties product line, shedding lower-margin and more cyclical operations to concentrate on its better businesses. How cleanly those exits flow through to a higher-margin, simpler company is the strategic milestone to watch.
The near-term operating picture is mixed and worth tracking by segment. First-quarter 2026 revenue rose 4.1% year over year to $258 million on pricing actions in Performance Materials and pavement technologies plus favorable foreign exchange, and adjusted earnings margin held around 35.5%. The soft spot was Performance Chemicals, where the adjusted earnings margin fell to about 1% on weak road-markings utilization and higher costs. Whether that segment's utilization recovers is the quarterly swing factor.
Guidance frames the full-year target. After updating its ranges for the road-markings divestiture, Ingevity reaffirmed 2026 net sales of $1.05 to $1.15 billion and adjusted earnings before interest, tax, depreciation and amortization of $370 to $395 million. Delivery against that range, paired with continued portfolio cleanup and share repurchases, is what the market will measure the repositioning against.
Peer Cohorts (Per Segment, With Filing Citations)
Performance Materials / Advanced Polymer Technologies (reported)
- AVNT (AVIENT CORPORATION)
- FY2025 10-K: …or reductions or significant facility operating problems. Other external factors beyond our control, including, but not limited to, trade barriers due to geopolitical tensions, can also cause fluctuations in raw materials prices, which could negatively impact demand for our products and cause volatility in our…
- FY2025 10-K: …No customer accounted for more than 3% of our consolidated revenues in 2025. Research and Development One of our strategic drivers is to "Amplify Innovation," and we have substantial technology and development capabilities, powered by approximately 1,100 employees serving in technical capacities, approximately 120 of…
- CE (CELANESE CORPORATION)
- FY2025 10-K: Asia and consist of 51 global production facilities and an additional 20 strategic affiliate production facilities. As of December 31, 2025, we employed 11,434 people worldwide. Business Segment Overview We operate principally through two business segments: Engineered Materials and the Acetyl Chain. See Business…
- FY2025 10-K: …and withstanding deformation. Nylon compounds are used in a range of applications including automotive, consumer, electrical, electronic and industrial. These value-added applications in diverse end uses support the business' global growth objectives. POM, PBT and LFRT are used in a broad range of…
- EMN (EASTMAN CHEMICAL CO)
- FY2025 10-K: …polymers, films, and plastics with differentiated performance properties for value-added end-uses in transportation; durables and electronics; building and construction; medical and pharma; and consumables end-markets. Key technology platforms for this segment include cellulosic biopolymers, copolyesters, and PVB and…
- FY2025 10-K: …and assess performance of the Company. The CODM evaluates segment operating performance, and makes resource allocation and performance evaluation decisions, based on Adjusted EBIT, defined as the GAAP measure earnings before interest and taxes ("EBIT"), adjusted for non-core, unusual, or non-recurring items. These…
- HUN (Huntsman Corporation)
- FY2025 10-K: …of suppliers. We consume certain amines produced by our Performance Products segment and isocyanates produced by our Polyurethanes segment, which we use to formulate our Advanced Materials products. For additional information about our risks of raw material supply chain disruptions, see "Part I. Item 1A. Risk…
- FY2025 10-K: …aluminum panels and other steel materials to lighten structures in aerospace, automotive and other transportation. Our Advanced Materials segment is characterized by the breadth of our product offering, our expertise in complex chemistry, our long-standing relationships with our customers, our ability to develop and…
- CC (Chemours Co)
- FY2025 10-K: …the cyclicality of key end markets, such as industrial, chemical processing, consumer goods, and transportation, and is expected to grow in line with GDP. However, with growing demand for cleaner and faster technologies, demand for products in the performance solutions portfolio is expected to grow at a rate faster…
- FY2025 10-K: …by product line and markets served. Our Advanced Performance Materials segment maintains a fleet of railcars, tank trucks, containers, and totes to deliver our products and support our supply chain needs. For the portion of the fleet that is leased, the related lease terms are usually staggered, which provides us…
- ROG (Rogers Corporation)
- FY2025 10-K: …Our competitors include commodity materials suppliers, which offer product substitutions based mostly on price, and suppliers of alternate solutions, which offer product substitutions or eliminations based mostly on disruptive technology. Certain of these competitors have greater financial and other resources than we…
- FY2025 10-K: …the loss of any one of our larger customers would require a period of adjustment, during which the results of operations could be materially adversely impacted, we believe that such events could be successfully mitigated over a period of time due to the diversity of our customer base. We employ a technical sales and…
Performance Chemicals (reported)
- IOSP (INNOSPEC INC.)
- FY2025 10-K: …fuel efficiency, boost engine performance and reduce harmful emissions. Our Oilfield Services business supplies chemicals for drilling, completion, production and drag reducing agents ("DRA") which make oil and gas exploration and production more cost-efficient and environmentally friendly. Segment Information The…
- FY2025 10-K: …and Chief Executive Officer (the Principal Executive Officer). The CODM evaluates the performance of the Company's segments and makes strategic decisions relating to the Company's allocation of resources, based on the segments' monthly gross profit and operating income. The following table analyzes financial…
- KWR (QUAKER CHEMICAL CORPORATION)
- FY2025 10-K: …through its own employees and its Fluidcare TM programs, with the balance sold through distributors and agents. The Company's employees typically visit the plants of customers regularly, work on site, and through training and experience, identify production needs which can be resolved or otherwise addressed either by…
- FY2025 10-K: …customer could have a material adverse effect on our business. 7 We may not be able to timely develop, manufacture and gain market acceptance of new and enhanced products required to maintain or expand our business, which could adversely affect our competitive position and our liquidity, financial position and…
- CC (Chemours Co)
- FY2025 10-K: …the cyclicality of key end markets, such as industrial, chemical processing, consumer goods, and transportation, and is expected to grow in line with GDP. However, with growing demand for cleaner and faster technologies, demand for products in the performance solutions portfolio is expected to grow at a rate faster…
- FY2025 10-K: …and purity as required by the electronics, communications, automotive, wire and cable, battery, fuel cell, water electrolysis, and other industries. Additionally, our Advanced Performance Materials segment is a leader in and holds patents relating to non-fluorinated materials for use as durable water repellents for…
- FUL (FULLER H B CO)
- FY2025 10-K: …new high-performance solutions that enable customers to improve their products and processes to better achieve their sustainability programs. Regulatory Compliance The Company is subject to various federal, state, local and foreign laws and regulations relating to environmental protection and workers' safety,…
- FY2025 10-K: Research and Development Our investment in research and development creates new and innovative adhesive technology platforms, enhances product performance, ensures a competitive cost structure and leverages available raw materials. New product development is a key research and development outcome, providing…
- ECVT (Ecovyst Inc.)
- FY2025 10-K: …raw materials include spent sulfuric acid, sulfur, acids, bases (including sodium hydroxide, or "caustic soda") and certain metals. Spent sulfuric acid for our regeneration services product group is supplied by customers as part of their contracts. Most of our contracts feature take-or-pay volume protection and/or…
- FY2025 10-K: …with performance conditions stipulate that the performance vesting condition can be attained for a period of six months following separation from service under certain circumstances, depending on the means of separation from the Company and subject to other factors such as individual separation agreements. The same…
- PRM (PERIMETER SOLUTIONS, INC.)
- FY2025 10-K: …added Per- and polyfluoroalkyl ("PFAS") substances. We expect Fluorine-Free Foams ("FFF") to account for a growing percentage of the firefighting foam market over the next several years. We believe that we are a leader in the FFF market. Specialty Products Segment P 2 S 5 is primarily used in the preparation of…
- FY2025 10-K: …specialized equipment, and services. As a result, development and testing of products, and the approval and licensing of such products, is typically a complex and lengthy process. Our retardant products compete with similar solutions, including gels, foams, and water, in addition to numerous global and domestic…
Methodology Note
- Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
- Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
- Economic-unit decomposition (SOTP): each disclosed business unit is assigned its native valuation basis before any multiple is applied. Operating units are valued on enterprise value; funded financial units are valued on their own common equity, because their borrowings fund earning assets rather than levering the parent. A company total is stated only once every material unit carries a supported value and the parent capital bridge reconciles.
- Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
- Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.
Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.
Sources
company 10-K, fiscal 2024 · Ingevity Q1 2026 results